Title: Management of type 1 gastric neuroendocrine tumors: An 11-year retrospective single-
center study
Version: 4 Date: 08 Nov 2023
Reviewer's report:
Dear Authors,
I have carefully reviewed your manuscript and I am pleased to report that it has improved
significantly since the previous version.
However, I have a few suggestions that could further improve the manuscript. First, I would
recommend that you provide more detail about the endoscopic findings of the gastric NETs,
such as the presence of any other endoscopic abnormalities, such as polyps also non-NET (as
previously reported see PMID: 36858908).  Even if not reported, please comment.
Second, I would recommend that you discuss the potential role of proton pump inhibitors
(PPIs) in developing gastric NETs. There is some evidence that PPIs may increase the risk of
developing gastric NETs, (see PMID: 26059834). Again, even if not reported, please comment.
These suggestions would make your manuscript even more informative and valuable.
Title: Management of type 1 gastric neuroendocrine tumors: An 11-year retrospective single-
center study
Version: 4 Date: 08 Nov 2023
Reviewer's report:
Dear Authors,
I have carefully reviewed your manuscript and I am pleased to report that it has improved
significantly since the previous version.
However, I have a few suggestions that could further improve the manuscript. First, I would
recommend that you provide more detail about the endoscopic findings of the gastric NETs,
such as the presence of any other endoscopic abnormalities, such as polyps also non-NET (as
previously reported see PMID: 36858908).  Even if not reported, please comment.
Second, I would recommend that you discuss the potential role of proton pump inhibitors
(PPIs) in developing gastric NETs. There is some evidence that PPIs may increase the risk of
developing gastric NETs, (see PMID: 26059834). Again, even if not reported, please comment.
These suggestions would make your manuscript even more informative and valuable.
Please review this paper.
user
Title: Management of type 1 gastric neuroendocrine tumors: An 11-year retrospective single-
center study
Version: 4 Date: 08 Nov 2023
Reviewer's report:
Dear Authors,
I have carefully reviewed your manuscript and I am pleased to report that it has improved
significantly since the previous version.
However, I have a few suggestions that could further improve the manuscript. First, I would
recommend that you provide more detail about the endoscopic findings of the gastric NETs,
such as the presence of any other endoscopic abnormalities, such as polyps also non-NET (as
previously reported see PMID: 36858908).  Even if not reported, please comment.
Second, I would recommend that you discuss the potential role of proton pump inhibitors
(PPIs) in developing gastric NETs. There is some evidence that PPIs may increase the risk of
developing gastric NETs, (see PMID: 26059834). Again, even if not reported, please comment.
These suggestions would make your manuscript even more informative and valuable.
assistant